Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review
2024-01-01 Rogliani, P.; Manzetti, G. M.; Bettin, F. R.; D'Auria, M.; Calzetta, L.
Delivering monoclonal antibodies via inhalation: a systematic review of clinical trials in asthma and COPD
2023-01-01 Laitano, R.; Calzetta, L.; Cavalli, F.; Cazzola, M.; Rogliani, P.
Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval
2023-01-01 Calzetta, L.; Pistocchini, E.; Chetta, A.; Rogliani, P.; Cazzola, M.
Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement
2024-01-01 Laitano, R.; Calzetta, L.; Matino, M.; Pistocchini, E.; Rogliani, P.
The novel inhaled dual PDE3 and PDE4 inhibitor ensifentrine for the treatment of COPD: A systematic review and meta-analysis protocol on trough FEV1 and exacerbation according to PRISMA statement
2024-01-01 Calzetta, L.; Cazzola, M.; Gholamalishahi, S.; Rogliani, P.
The Impact of Thermal Water in Asthma and COPD: A Systematic Review According to the PRISMA Statement
2024-01-01 Calzetta, L.; Di Daniele, N.; Chetta, A.; Vitale, M.; Gholamalishahi, S.; Cazzola, M.; Rogliani, P.
Excellence paves the way with current research in pharmacology and drug discovery
2020-01-01 Calzetta, L.; Koziol-White, C.
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE Trials
2024-01-01 Calzetta, L.; Cazzola, M.; Rogliani, P.
Severe Asthma and Biological Therapy: When, Which, and for Whom
2020-01-01 Rogliani, P.; Calzetta, L.; Matera, M. G.; Laitano, R.; Ritondo, B. L.; Hanania, N. A.; Cazzola, M.
Response
2019-01-01 Calzetta, L.; Cazzola, M.; Matera, M. G.; Rogliani, P.
The discovery and development of gefapixant as a novel antitussive therapy
2024-01-01 Matera, M. G.; Rogliani, P.; Page, C. P.; Calzetta, L.; Cazzola, M.
Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database
2024-01-01 Cazzola, M.; Matera, M. G.; Calzetta, L.; Lauro, D.; Rogliani, P.
Systematic literature review of treatments used for refractory or unexplained chronic cough in adults
2024-01-01 Bali, V.; Kardos, P.; Page, C.; Rogliani, P.; Calzetta, L.; Adriano, A.; Byrne, A.; Adeyemi, A.; Frederickson, A.; Schelfhout, J.
Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023
2024-01-01 Matera, M. G.; Calzetta, L.; Rogliani, P.; Hanania, N.; Cazzola, M.
Pharmacokinetic considerations surrounding triple therapy for uncontrolled asthma
2023-01-01 Matera, M. G.; Rinaldi, B.; Belardo, C.; Calzetta, L.; Cazzola, M.
Doxofylline: Advancing and Empowering Equitable Asthma and COPD Management Beyond Tradition
2024-01-01 Cazzola, M.; Page, C. P.; Calzetta, L.; Rogliani, P.; Matera, M. G.
Clinically Important Deterioration (CID) and Ageing in COPD: A Systematic Review and Meta-Regression Analysis According to PRISMA Statement
2023-01-01 Manzetti, G. M.; Ora, J.; Sepiacci, A.; Cazzola, M.; Rogliani, P.; Calzetta, L.
What role will ensifentrine play in the future treatment of chronic obstructive pulmonary disease patients? Implications from recent clinical trials
2023-01-01 Cazzola, M.; Page, C.; Calzetta, L.; Singh, D.; Rogliani, P.; Matera, M. G.
Investigational anti IL-13 asthma treatments: a 2023 update
2023-01-01 Matera, M. G.; Ora, J.; Calzetta, L.; Rogliani, P.; Cazzola, M.
Assessing the relationship between cardiovascular and small airway disease and acute events in COPD: The ARCADIA study protocol
2023-01-01 Rogliani, P.; Radovanovic, D.; Ora, J.; Starc, N.; Verri, S.; Pistocchini, E.; Calzetta, L.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista72085
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa66
- 2020 - 202717165
- 2010 - 201923034
- 2000 - 200918345
- 1990 - 19998892
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI975
- Elsevier Ltd769
- Elsevier B.V.654
- MDPI AG497
- Elsevier394
- John Wiley and Sons Inc331
- Springer323
- Multidisciplinary Digital Publish...308
- Springer Science and Business Med...301
- Elsevier Inc.268
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE934
- PLOS ONE384
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS284
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...198
- DOCTOR. OS183
- ACTA BIOMEDICA182
- NUTRIENTS181
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2918
- Female1598
- Male1494
- Middle Aged905
- Adult898
- Aged761
- Animals656
- Italy594
- Medicine (all)464
- COVID-19460
Lingua
- eng43645
- ita9150
- fre232
- spa124
- ger102
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext58766
- reserved8053
- open3777
- partially open821
- restricted667
- embargoed2
- mixed1